Improved Growth in Ischemic Limbs with Gene-Modified Fibroblasts
Author Information
Author(s): Zhang Ziyang, Slobodianski Alex, Ito Wulf D., Arnold Astrid, Nehlsen Jessica, Weng Shaoxiang, Lund Natalie, Liu Jihong, Egaña José-Tomás, Lohmeyer Jörn A., Müller Daniel F., Machens Hans-Günther
Primary Institution: Technische Universität München
Hypothesis
Can double transplantation of gene-nucleofected fibroblasts enhance collateral growth in ischemic hindlimbs?
Conclusion
The study demonstrates that double transplantation of gene-nucleofected fibroblasts effectively promotes collateral circulation in ischemic hindlimbs.
Supporting Evidence
- Gene-modified fibroblasts increased the number of collateral vessels in ischemic limbs.
- Blood flow improved significantly in treated limbs compared to controls.
- The plasmid was detected at the injection site for over 28 days.
Takeaway
Scientists found a way to help sick legs heal better by using special cells that grow new blood vessels.
Methodology
Rats received injections of gene-modified fibroblasts after femoral artery ligation, and vascularization was assessed using micro-CT.
Potential Biases
Potential bias in the selection of animal models and the assessment of outcomes.
Limitations
The study was conducted in rats, and results may not directly translate to humans.
Participant Demographics
Male Lewis inbred rats, weight 200 grams.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website